Pharma Growth Rebounds: Drugmakers top 10% in March 2026 on pricing, new launches; Cipla, Glenmark lead – Markets

Pharma Growth Rebounds: Drugmakers top 10% in March 2026 on pricing, new launches; Cipla, Glenmark lead - Markets


In a separate event, Secretary of the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers, speaking at FICCI’s India Pharma 2026 event, said closer collaboration between the industry and the government is essential to push sectoral reforms with clearly defined timelines.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *